Meet The Speaker

Hangtian Song
BMS
About
Hangtian Song

Hangtian Song currently works in Biologics Development at Bristol-Myers Squibb Company. He is experienced in the characterization of protein therapeutics including monoclonal antibodies,
fusion proteins and antibody-drug conjugates using mass spectrometry, chromatography, and other biophysical techniques. He received his PhD in Analytical Chemistry from the University of Michigan at Ann Arbor. His research there focused on Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.